Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITOS
1601
DELISTED
iTeos Therapeutics
ITOS
| $2.7M | ﹤0.01% |
+83,999
| New | +$3.05M |
|
1602
Repligen
RGEN
$8.96B
| $2.7M | ﹤0.01% |
14,368
+1,168
| +9% | +$222K |
|
1603
WEX
WEX
$6.41B
| $2.69M | ﹤0.01% |
15,079
+5,850
| +63% | +$954K |
|
1604
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $2.69M | ﹤0.01% |
50,145
+17,340
| +53% | +$923K |
|
1605
Lumentum
LITE
$66.3B
| $2.69M | ﹤0.01% |
27,579
-15,859
| -37% | -$1.55M |
|
|
GOL
1606
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $2.69M | ﹤0.01% |
373,813
+29,200
| +8% | +$186K |
|
|
CPE
1607
DELISTED
Callon Petroleum Company
CPE
| $2.68M | ﹤0.01% |
+45,448
| New | +$2.49M |
|
1608
Suncor Energy
SU
$72B
| $2.68M | ﹤0.01% |
82,319
-2,375,322
| -97% | -$70.5M |
|
1609
SSR Mining
SSRM
$5.85B
| $2.68M | ﹤0.01% |
123,075
+90,540
| +278% | +$1.7M |
|
1610
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $2.67M | ﹤0.01% |
55,674
| – | – |
|
|
APLS
1611
DELISTED
Apellis Pharmaceuticals
APLS
| $2.67M | ﹤0.01% |
52,604
-92,644
| -64% | -$4.09M |
|
1612
Virtu Financial
VIRT
$4.91B
| $2.67M | ﹤0.01% |
71,778
+4,240
| +6% | +$140K |
|
|
EXE
1613
Expand Energy Corp
EXE
$21.2B
| $2.67M | ﹤0.01% |
+30,641
| New | +$2.25M |
|
|
THCA
1614
DELISTED
Tuscan Holdings Corp. II Common Stock
THCA
| $2.67M | ﹤0.01% |
+236,729
| New | +$2.43M |
|
1615
Emergent Biosolutions
EBS
$264M
| $2.65M | ﹤0.01% |
64,555
+684
| +1% | +$30.2K |
|
1616
Alarm.com
ALRM
$2.77B
| $2.65M | ﹤0.01% |
39,874
-22,726
| -36% | -$1.61M |
|
|
SPTN
1617
DELISTED
SpartanNash
SPTN
| $2.65M | ﹤0.01% |
80,218
-51,708
| -39% | -$1.46M |
|
1618
Advanced Energy
AEIS
$13.1B
| $2.64M | ﹤0.01% |
30,651
-20,078
| -40% | -$1.74M |
|
1619
Sabre
SABR
$862M
| $2.63M | ﹤0.01% |
230,481
+143,382
| +165% | +$1.4M |
|
|
RSX
1620
DELISTED
VanEck Russia ETF
RSX
| $2.63M | ﹤0.01% |
466,258
+231,670
| +99% | +$3.91M |
|
|
FBC
1621
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $2.63M | ﹤0.01% |
62,125
-86,404
| -58% | -$3.98M |
|
|
CLVT.PRA
1622
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $2.63M | ﹤0.01% |
+38,697
| New | +$2.62M |
|
1623
PRA Group
PRAA
$678M
| $2.62M | ﹤0.01% |
58,033
-29,060
| -33% | -$1.34M |
|
1624
Veeco
VECO
$3.18B
| $2.62M | ﹤0.01% |
96,240
-24,805
| -20% | -$699K |
|
|
AXON
1625
Axon Enterprise
AXON
$42B
| $2.61M | ﹤0.01% |
18,926
-12,630
| -40% | -$1.73M |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.